Next Article in Journal
Clove Buds Affect MCF-7 Breast Cancer Cell Stress/Survival Pathways and Induce Oxidative Stress, DNA Damage, Cell Cycle Arrest, and Apoptosis
Previous Article in Journal
Physicochemical and Pharmacokinetic Properties of New Dual-Acting Compounds for the Treatment of Mental Disorders
 
Search for Articles:
Title / Keyword
Author / Affiliation
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
Journals
Proceedings
Volume 22
Issue 1
10.3390/proceedings2019022049
proceedings-logo
Submit to this Journal
► Article Menu

Article Menu

share announcement thumb_up
...
textsms
...
Open AccessExtended Abstract

Novel Dual Ligands Targeting Sigma1 Receptor and Acetylcholinesterase Endowed with Antioxidant Properties†

by
Giacomo Rossino
1,
Marta Rui
1,
Dirk Schepmann
2,
Bernard Wünsch
2,
Stefania Monteleone
3,4,
Klaus Liedl
4,
Vittorio Pace
5,
Daniela Rossi
1 and
Simona Collina
1,*
1
Department of Drug Sciences, Medicinal Chemistry and Pharmaceutical Technology Section, University of Pavia, Viale Taramelli 6 and 12, 27100 Pavia, Italy
2
Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Correnstrasse 48, 48149 Muenster, Germany
3
Department of Pharmaceutical Chemistry, Philipps-University Marburg, Marbacher Weg 6, 35032 Marburg, Germany
4
Institute of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria
5
Department of Pharmaceutical Chemistry, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria
*
Author to whom correspondence should be addressed.
†
Presented at the 2nd Molecules Medicinal Chemistry Symposium (MMCS): Facing Novel Challenges in Drug Discovery, Barcelona, Spain, 15–17 May 2019.
†
Presented at the 2nd Molecules Medicinal Chemistry Symposium (MMCS): Facing Novel Challenges in Drug Discovery, Barcelona, Spain, 15–17 May 2019.
Proceedings 2019, 22(1), 49; https://doi.org/10.3390/proceedings2019022049
Published: 8 August 2019
(This article belongs to the Proceedings of The 2nd Molecules Medicinal Chemistry Symposium (MMCS): Facing Novel Challenges in Drug Discovery)
Download PDF

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Neurodegenerative disorders represent one of the main therapeutic challenges of our time. [...]
Keywords: neurodegenerative disorders, Sigma1 receptor agonist, RC-33; structure optimization neurodegenerative disorders, Sigma1 receptor agonist, RC-33; structure optimization
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
SciFeed

Share and Cite

MDPI and ACS Style

Rossino, G.; Rui, M.; Schepmann, D.; Wünsch, B.; Monteleone, S.; Liedl, K.; Pace, V.; Rossi, D.; Collina, S. Novel Dual Ligands Targeting Sigma1 Receptor and Acetylcholinesterase Endowed with Antioxidant Properties. Proceedings 2019, 22, 49. https://doi.org/10.3390/proceedings2019022049

AMA Style

Rossino G, Rui M, Schepmann D, Wünsch B, Monteleone S, Liedl K, Pace V, Rossi D, Collina S. Novel Dual Ligands Targeting Sigma1 Receptor and Acetylcholinesterase Endowed with Antioxidant Properties. Proceedings. 2019; 22(1):49. https://doi.org/10.3390/proceedings2019022049

Chicago/Turabian Style

Rossino, Giacomo; Rui, Marta; Schepmann, Dirk; Wünsch, Bernard; Monteleone, Stefania; Liedl, Klaus; Pace, Vittorio; Rossi, Daniela; Collina, Simona. 2019. "Novel Dual Ligands Targeting Sigma1 Receptor and Acetylcholinesterase Endowed with Antioxidant Properties" Proceedings 22, no. 1: 49. https://doi.org/10.3390/proceedings2019022049

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Map by Country/Region

1
Back to TopTop